1.60
price up icon2.56%   0.04
after-market アフターアワーズ: 1.62 0.02 +1.25%
loading
前日終値:
$1.56
開ける:
$1.6
24時間の取引高:
2.06M
Relative Volume:
1.21
時価総額:
$211.37M
収益:
-
当期純損益:
$-67.68M
株価収益率:
-0.9639
EPS:
-1.66
ネットキャッシュフロー:
$-54.24M
1週間 パフォーマンス:
-9.60%
1か月 パフォーマンス:
-22.33%
6か月 パフォーマンス:
-31.33%
1年 パフォーマンス:
-78.35%
1日の値動き範囲:
Value
$1.58
$1.6794
1週間の範囲:
Value
$1.51
$1.77
52週間の値動き範囲:
Value
$0.9857
$8.77

Cabaletta Bio Inc Stock (CABA) Company Profile

Name
名前
Cabaletta Bio Inc
Name
セクター
Healthcare (1166)
Name
電話
(267) 759-3100
Name
住所
2929 ARCH STREET, PHILADELPHIA, PA
Name
職員
163
Name
Twitter
@CabalettaBio
Name
次回の収益日
2025-03-31
Name
最新のSEC提出書
Name
CABA's Discussions on Twitter

CABA を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
CABA
Cabaletta Bio Inc
1.60 211.37M 0 -67.68M -54.24M -1.66
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
457.03 115.95B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
547.74 56.52B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
329.77 39.44B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
545.11 35.14B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
244.32 28.51B 3.81B -644.79M -669.77M -6.24

Cabaletta Bio Inc Stock (CABA) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2024-12-20 ダウングレード Evercore ISI Outperform → In-line
2024-12-19 ダウングレード Wells Fargo Overweight → Equal Weight
2024-10-10 開始されました UBS Buy
2024-02-05 開始されました Jefferies Buy
2023-11-29 開始されました William Blair Outperform
2023-10-24 開始されました Cantor Fitzgerald Overweight
2023-10-19 開始されました Stifel Buy
2023-09-05 開始されました Citigroup Buy
2023-07-18 開始されました Guggenheim Buy
2023-01-27 アップグレード Morgan Stanley Equal-Weight → Overweight
2022-08-30 ダウングレード Morgan Stanley Overweight → Equal-Weight
2021-12-08 開始されました Wells Fargo Overweight
2021-10-19 再開されました Morgan Stanley Overweight
2021-06-30 開始されました Mizuho Buy
2021-01-08 開始されました Chardan Capital Markets Buy
2020-10-13 開始されました H.C. Wainwright Buy
2019-11-19 開始されました Cowen Outperform
2019-11-19 開始されました Evercore ISI Outperform
2019-11-19 開始されました Morgan Stanley Overweight
すべてを表示

Cabaletta Bio Inc (CABA) 最新ニュース

pulisher
Jun 17, 2025

Analysts Set Cabaletta Bio, Inc. (NASDAQ:CABA) PT at $20.33 - MarketBeat

Jun 17, 2025
pulisher
Jun 16, 2025

Cabaletta Bio's SWOT analysis: CAR-T pioneer's stock faces market skepticism - Investing.com Australia

Jun 16, 2025
pulisher
Jun 16, 2025

Cabaletta Bio’s SWOT analysis: CAR-T pioneer’s stock faces market skepticism - Investing.com Australia

Jun 16, 2025
pulisher
Jun 16, 2025

Cabaletta Bio’s SWOT analysis: CAR-T pioneer’s stock faces market skepticism By Investing.com - Investing.com South Africa

Jun 16, 2025
pulisher
Jun 14, 2025

Cantor Fitzgerald Weighs in on Cabaletta Bio FY2026 Earnings - MarketBeat

Jun 14, 2025
pulisher
Jun 14, 2025

Cabaletta Bio's (CABA) "Buy" Rating Reiterated at HC Wainwright - MarketBeat

Jun 14, 2025
pulisher
Jun 14, 2025

Cabaletta Bio Reports Promising Data from RESET Trials for Transformative Autoimmune Therapy - MSN

Jun 14, 2025
pulisher
Jun 13, 2025

Cabaletta Bio stock price target reiterated on strong clinical data By Investing.com - Investing.com India

Jun 13, 2025
pulisher
Jun 13, 2025

Cabaletta Bio stock price target reiterated on strong clinical data - Investing.com

Jun 13, 2025
pulisher
Jun 13, 2025

Cabaletta Bio Prices Public Offering to Raise $100 Million - MSN

Jun 13, 2025
pulisher
Jun 12, 2025

Cabaletta Bio Announces Public Offering of Common Stock and Warrants - MSN

Jun 12, 2025
pulisher
Jun 12, 2025

H.C. Wainwright reiterates buy rating on Cabaletta Bio stock By Investing.com - Investing.com Nigeria

Jun 12, 2025
pulisher
Jun 12, 2025

H.C. Wainwright reiterates buy rating on Cabaletta Bio stock - Investing.com Australia

Jun 12, 2025
pulisher
Jun 12, 2025

Cabaletta Bio’s (CABA) Buy Rating Reaffirmed at HC Wainwright - Defense World

Jun 12, 2025
pulisher
Jun 12, 2025

Analysts Offer Predictions for Cabaletta Bio FY2026 Earnings - Defense World

Jun 12, 2025
pulisher
Jun 11, 2025

Cabaletta Bio Launches Public Offering Of Stock And Warrants - Nasdaq

Jun 11, 2025
pulisher
Jun 11, 2025

Cabaletta Bio (CABA) Shares Drop 20% After Public Offering Annou - GuruFocus

Jun 11, 2025
pulisher
Jun 11, 2025

Cabaletta Bio (CABA) Showcases Promising Rese-cel Data at EULAR 2025 | CABA Stock News - GuruFocus

Jun 11, 2025
pulisher
Jun 11, 2025

Cabaletta Bio announces public offering of common stock and warrants By Investing.com - Investing.com South Africa

Jun 11, 2025
pulisher
Jun 11, 2025

Cabaletta Bio prices $100 million public offering of shares and warrants By Investing.com - Investing.com South Africa

Jun 11, 2025
pulisher
Jun 11, 2025

Cabaletta reports positive clinical data for autoimmune cell therapy By Investing.com - Investing.com South Africa

Jun 11, 2025
pulisher
Jun 11, 2025

Cabaletta Bio looks to raise $100M in stock sale to fund cell therapy development - The Business Journals

Jun 11, 2025
pulisher
Jun 11, 2025

Cabaletta Bio (CABA) Receives Reiterated Buy Rating from HC Wain - GuruFocus

Jun 11, 2025
pulisher
Jun 11, 2025

Cabaletta Bio (CABA) Receives Reiterated Buy Rating from HC Wainwright & Co. | CABA Stock News - GuruFocus

Jun 11, 2025
pulisher
Jun 11, 2025

Cabaletta Bio shares CAR-T results in three autoimmune conditions - Endpoints News

Jun 11, 2025
pulisher
Jun 11, 2025

Cabaletta Bio Prices Securities Offering; Shares Fall - MarketScreener

Jun 11, 2025
pulisher
Jun 11, 2025

Cabaletta Bio stock tumbles after pricing $100 million public offering By Investing.com - Investing.com Nigeria

Jun 11, 2025
pulisher
Jun 11, 2025

Cabaletta Bio stock tumbles after pricing $100 million public offering - Investing.com Australia

Jun 11, 2025
pulisher
Jun 11, 2025

Cabaletta Bio Announces Pricing of Public Offering of Securities - GuruFocus

Jun 11, 2025
pulisher
Jun 11, 2025

Cabaletta Bio prices $100 million public offering of shares and warrants - Investing.com

Jun 11, 2025
pulisher
Jun 11, 2025

Cabaletta Bio: Sector Headwinds And Funding Issues, But Also Some Clear Clinical Direction - Seeking Alpha

Jun 11, 2025
pulisher
Jun 11, 2025

Cabaletta Bio announces public offering of common stock and warrants - Investing.com

Jun 11, 2025
pulisher
Jun 11, 2025

Cabaletta Bio (CABA) Launches Public Offering with Warrants | CABA Stock News - GuruFocus

Jun 11, 2025
pulisher
Jun 11, 2025

Cabaletta Bio Announces Proposed Public Offering of Securities | - GuruFocus

Jun 11, 2025
pulisher
Jun 11, 2025

Cabaletta Bio Announces Proposed Public Offering of Securities - The Manila Times

Jun 11, 2025
pulisher
Jun 11, 2025

Cabaletta Bio Announces Proposed Public Offering of Securities | CABA Stock News - GuruFocus

Jun 11, 2025
pulisher
Jun 11, 2025

Cabaletta Bio Announces New Rese-cel Safety and Efficacy Data in - GuruFocus

Jun 11, 2025
pulisher
Jun 11, 2025

Cabaletta Bio Announces New Rese-cel Safety and Efficacy Data in Patients with Myositis, Lupus and Scleroderma to Be Presented at the EULAR 2025 Congress | CABA Stock News - GuruFocus

Jun 11, 2025
pulisher
Jun 11, 2025

Cabaletta Bio Announces New Rese-cel Safety and Efficacy Data in Patients with Myositis, Lupus and Scleroderma to Be Presented at the EULAR 2025 Congress - The Manila Times

Jun 11, 2025
pulisher
Jun 11, 2025

Cabaletta reports positive clinical data for autoimmune cell therapy - Investing.com

Jun 11, 2025
pulisher
Jun 11, 2025

Breakthrough: New Autoimmune Therapy Achieves Drug-Free Remission in 94% of Trial Patients - Stock Titan

Jun 11, 2025
pulisher
Jun 10, 2025

Cabaletta Bio Stockholders Approve Key Proposals - TipRanks

Jun 10, 2025

Cabaletta Bio Inc (CABA) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$20.44
price down icon 1.45%
$36.19
price up icon 0.86%
$22.62
price up icon 6.70%
$98.24
price up icon 0.64%
$108.26
price up icon 0.70%
biotechnology ONC
$244.32
price down icon 0.34%
大文字化:     |  ボリューム (24 時間):